


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 26 May 2007
AMO Announces Voluntary Recall of Complete(R) MoisturePlus(TM) Multipurpose Solution
AMO Announces Voluntary Recall of Complete(R) MoisturePlus(TM) Multipurpose Solution
HSMN NewsFeed - 25 May 2007
Ipsen: Increlex(R) Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
Ipsen: Increlex(R) Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
HSMN NewsFeed - 24 May 2007
BioMarin Submits New Drug Application for U.S. Marketing Authorization of Kuvan for Phenylketonuria (PKU)
BioMarin Submits New Drug Application for U.S. Marketing Authorization of Kuvan for Phenylketonuria (PKU)
HSMN NewsFeed - 23 May 2007
Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
HSMN NewsFeed - 23 May 2007
Conatus Pharmaceuticals Elects Harold E. Van Wart, Ph.D., to Its Board of Directors
Conatus Pharmaceuticals Elects Harold E. Van Wart, Ph.D., to Its Board of Directors
HSMN NewsFeed - 22 May 2007
Hi-Tech Pharmacal's Founder and Chairman Emeritus, Bernard Seltzer Dies at Age 83
Hi-Tech Pharmacal's Founder and Chairman Emeritus, Bernard Seltzer Dies at Age 83
HSMN NewsFeed - 22 May 2007
Hana Biosciences Announces Vice President Appointment in Regulatory Affairs and Quality Assurance
Hana Biosciences Announces Vice President Appointment in Regulatory Affairs and Quality Assurance
HSMN NewsFeed - 22 May 2007
Javelin Pharmaceuticals Signs Commercial Supply Agreement with Baxter Healthcare Corporation
Javelin Pharmaceuticals Signs Commercial Supply Agreement with Baxter Healthcare Corporation
HSMN NewsFeed - 22 May 2007
CytRx Names Shi Chung Ng, Ph.D., Senior Vice President of Research and Development
CytRx Names Shi Chung Ng, Ph.D., Senior Vice President of Research and Development
HSMN NewsFeed - 22 May 2007
Victory Pharma, Inc. Announces Dr. Shawn A. Scranton as Vice President of Scientific Operations
Victory Pharma, Inc. Announces Dr. Shawn A. Scranton as Vice President of Scientific Operations
HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
HSMN NewsFeed - 21 May 2007
Data Suggest Cymbalta(R) Improved Functioning in Patients With Generalized Anxiety Disorder
Data Suggest Cymbalta(R) Improved Functioning in Patients With Generalized Anxiety Disorder
HSMN NewsFeed - 21 May 2007
Idera Pharmaceuticals Announces Chief Financial Officer to Leave Company Effective July 31, 2007
Idera Pharmaceuticals Announces Chief Financial Officer to Leave Company Effective July 31, 2007
HSMN NewsFeed - 21 May 2007
U.S. FDA Approves VELCADE(R) + DOXIL(R) Combination for Treatment of Relapsed/Refractory Multiple Myeloma
U.S. FDA Approves VELCADE(R) + DOXIL(R) Combination for Treatment of Relapsed/Refractory Multiple Myeloma
HSMN NewsFeed - 21 May 2007
Data Suggest that PEGASYS(R) May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron(R)
Data Suggest that PEGASYS(R) May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron(R)
HSMN NewsFeed - 21 May 2007
Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer's Disease
Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer's Disease
HSMN NewsFeed - 20 May 2007
Merck Announces Resignation of Peter Loescher, President, Global Human Health
Merck Announces Resignation of Peter Loescher, President, Global Human Health
HSMN NewsFeed - 20 May 2007
Pfizer Says Research and Development Head John LaMattina Will Retire This Year
Pfizer Says Research and Development Head John LaMattina Will Retire This Year
HSMN NewsFeed - 18 May 2007
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
HSMN NewsFeed - 18 May 2007
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
HSMN NewsFeed - 17 May 2007
FDA Advisory Committee Unanimously Votes in Favor of Acambis' Smallpox Vaccine
FDA Advisory Committee Unanimously Votes in Favor of Acambis' Smallpox Vaccine
HSMN NewsFeed - 17 May 2007
DURECT Provides an Update to the Memryte(TM) Program Under Development by Voyager Pharmaceutical Corp
DURECT Provides an Update to the Memryte(TM) Program Under Development by Voyager Pharmaceutical Corp
HSMN NewsFeed - 17 May 2007
HEALTHPOINT's J.R. Locey Promoted to Vice President of Strategic and Business Development
HEALTHPOINT's J.R. Locey Promoted to Vice President of Strategic and Business Development
HSMN NewsFeed - 17 May 2007
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
HSMN NewsFeed - 17 May 2007
Cortex's AMPAKINE(R) Drug May Offer New Hope for Memory Problems Associated with Huntington's Disease
Cortex's AMPAKINE(R) Drug May Offer New Hope for Memory Problems Associated with Huntington's Disease
HSMN NewsFeed - 17 May 2007
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
HSMN NewsFeed - 17 May 2007
Cardinal Health Names Scott Storrer Group President, Healthcare Supply Chain Services-Pharmaceutical
Cardinal Health Names Scott Storrer Group President, Healthcare Supply Chain Services-Pharmaceutical
HSMN NewsFeed - 17 May 2007
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
HSMN NewsFeed - 16 May 2007
Barrier Therapeutics Appoints Dr. Braham Shroot, Dermatology Expert, as New Chief Scientific Officer
Barrier Therapeutics Appoints Dr. Braham Shroot, Dermatology Expert, as New Chief Scientific Officer
HSMN NewsFeed - 16 May 2007
Genzyme Announces Positive Initial Observations in Trial Evaluating Novel Oral Treatment for Gaucher Disease
Genzyme Announces Positive Initial Observations in Trial Evaluating Novel Oral Treatment for Gaucher Disease
HSMN NewsFeed - 16 May 2007
Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
HSMN NewsFeed - 16 May 2007
Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors
Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors
HSMN NewsFeed - 16 May 2007
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
HSMN NewsFeed - 15 May 2007
Point Therapeutics Announces Interim Analysis to be Performed on Its Phase 3 Talabostat with Alimta Study
Point Therapeutics Announces Interim Analysis to be Performed on Its Phase 3 Talabostat with Alimta Study
HSMN NewsFeed - 15 May 2007
President and CEO of Advanced Viral Research Corp. Signs on for an Additional Two Years
President and CEO of Advanced Viral Research Corp. Signs on for an Additional Two Years
HSMN NewsFeed - 15 May 2007
Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical Officer
Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical Officer
HSMN NewsFeed - 15 May 2007
Cougar Biotechnology Announces Additions to Clinical Research and Development Team
Cougar Biotechnology Announces Additions to Clinical Research and Development Team
HSMN NewsFeed - 15 May 2007
Achillion Appoints OSI Executive Robert Van Nostrand to Board of Directors
Achillion Appoints OSI Executive Robert Van Nostrand to Board of Directors
HSMN NewsFeed - 15 May 2007
IR BioSciences Appoints Former VaxGen Chief Executive Lance K. Gordon Ph.D. to Its Board of Directors
IR BioSciences Appoints Former VaxGen Chief Executive Lance K. Gordon Ph.D. to Its Board of Directors
HSMN NewsFeed - 14 May 2007
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
HSMN NewsFeed - 14 May 2007
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
HSMN NewsFeed - 14 May 2007
Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
HSMN NewsFeed - 14 May 2007
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
HSMN NewsFeed - 11 May 2007
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
HSMN NewsFeed - 11 May 2007
Mersana Therapeutics, Inc. Announces the Appointment of Robert J. Fram, M.D. as Chief Medical Officer
Mersana Therapeutics, Inc. Announces the Appointment of Robert J. Fram, M.D. as Chief Medical Officer
HSMN NewsFeed - 10 May 2007
La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer
La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer
HSMN NewsFeed - 10 May 2007
Bristol-Myers Squibb Announces Agreement in Principle to Resolve Federal Antitrust Investigation
Bristol-Myers Squibb Announces Agreement in Principle to Resolve Federal Antitrust Investigation
HSMN NewsFeed - 10 May 2007
ProCertus BioPharm, Inc. Closes $2.3 Million Series A Financing Led by Venture Investors LLC
ProCertus BioPharm, Inc. Closes $2.3 Million Series A Financing Led by Venture Investors LLC
HSMN NewsFeed - 10 May 2007
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
HSMN NewsFeed - 9 May 2007
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 9 May 2007
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
HSMN NewsFeed - 9 May 2007
Poniard Pharmaceuticals Appoints Ronald A. Martell President and Chief Operating Officer
Poniard Pharmaceuticals Appoints Ronald A. Martell President and Chief Operating Officer
HSMN NewsFeed - 9 May 2007
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program
HSMN NewsFeed - 9 May 2007
Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals
Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals
HSMN NewsFeed - 9 May 2007
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
HSMN NewsFeed - 9 May 2007
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
HSMN NewsFeed - 8 May 2007
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
HSMN NewsFeed - 7 May 2007
Bill Cadwallader Joins Velcura Therapeutics, Inc. as Executive Vice President of Corporate Development
Bill Cadwallader Joins Velcura Therapeutics, Inc. as Executive Vice President of Corporate Development
HSMN NewsFeed - 7 May 2007
Nymox Announces New Positive Results from 3 1/2 Year Study of NX-1207 for Benign Prostatic Hyperplasia
Nymox Announces New Positive Results from 3 1/2 Year Study of NX-1207 for Benign Prostatic Hyperplasia
HSMN NewsFeed - 7 May 2007
Early Results of the CellCept(R) Spare the Nephron Study Examine Kidney Function
Early Results of the CellCept(R) Spare the Nephron Study Examine Kidney Function
HSMN NewsFeed - 7 May 2007
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
HSMN NewsFeed - 7 May 2007
OMRIX Biopharmaceuticals Submits Regulatory Filing for Hepatitis B Immunoglobulin (HBIG) in Sweden
OMRIX Biopharmaceuticals Submits Regulatory Filing for Hepatitis B Immunoglobulin (HBIG) in Sweden
HSMN NewsFeed - 7 May 2007
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
HSMN NewsFeed - 7 May 2007
Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
HSMN NewsFeed - 4 May 2007
Xcellerex Announces Appointment of Joseph Zakrzewski as Chief Executive Officer
Xcellerex Announces Appointment of Joseph Zakrzewski as Chief Executive Officer
HSMN NewsFeed - 4 May 2007
Abbott's Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
Abbott's Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
HSMN NewsFeed - 4 May 2007
Dyax Announces the Resignation of Thomas Beck, M.D., President and Chief Operating Officer
Dyax Announces the Resignation of Thomas Beck, M.D., President and Chief Operating Officer
HSMN NewsFeed - 3 May 2007
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-TRAMADOL ER
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-TRAMADOL ER
HSMN NewsFeed - 3 May 2007
Barrier Therapeutics Receives FDA Approval for Solagé(R) Topical Solution Labeling Expansion
Barrier Therapeutics Receives FDA Approval for Solagé(R) Topical Solution Labeling Expansion
HSMN NewsFeed - 3 May 2007
Metabolex Names Charpentier to the Post of Vice President for Regulatory Affairs
Metabolex Names Charpentier to the Post of Vice President for Regulatory Affairs
HSMN NewsFeed - 3 May 2007
Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
HSMN NewsFeed - 3 May 2007
Avalon Pharmaceuticals, Inc. Names C. Eric Winzer New Chief Financial Officer
Avalon Pharmaceuticals, Inc. Names C. Eric Winzer New Chief Financial Officer
HSMN NewsFeed - 2 May 2007
Once-yearly Reclast(R) Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis
Once-yearly Reclast(R) Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis
HSMN NewsFeed - 2 May 2007
MINRAD International, Inc. Announces FDA Approval of Sojourn(TM) Sevoflurane
MINRAD International, Inc. Announces FDA Approval of Sojourn(TM) Sevoflurane
HSMN NewsFeed - 2 May 2007
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
HSMN NewsFeed - 2 May 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
HSMN NewsFeed - 2 May 2007
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
HSMN NewsFeed - 2 May 2007
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
HSMN NewsFeed - 2 May 2007
PTC Therapeutics Announces Promotion of Neil Almstead to Senior Vice President of Chemistry and CMC
PTC Therapeutics Announces Promotion of Neil Almstead to Senior Vice President of Chemistry and CMC
HSMN NewsFeed - 2 May 2007
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
HSMN NewsFeed - 1 May 2007
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
HSMN NewsFeed - 1 May 2007
New Data Shows Once a Day Lamictal(R) XR(TM) Is Effective in Treating Patients With Partial Seizures
New Data Shows Once a Day Lamictal(R) XR(TM) Is Effective in Treating Patients With Partial Seizures
HSMN NewsFeed - 1 May 2007
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
HSMN NewsFeed - 1 May 2007
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
HSMN NewsFeed - 1 May 2007
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
HSMN NewsFeed - 1 May 2007
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
HSMN NewsFeed - 1 May 2007
New Hampshire Law Banning Commercial Use of Prescription Information Declared Unconstitutional
New Hampshire Law Banning Commercial Use of Prescription Information Declared Unconstitutional
HSMN NewsFeed - 30 Apr 2007
Enzon Receives FDA Clearance of Its Recently Filed PEG-SN38 IND Application
Enzon Receives FDA Clearance of Its Recently Filed PEG-SN38 IND Application
HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
HSMN NewsFeed - 30 Apr 2007
Dr Reddy's launches Reditux(TM) - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
Dr Reddy's launches Reditux(TM) - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
HSMN NewsFeed - 30 Apr 2007
RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery
RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery
HSMN NewsFeed - 30 Apr 2007
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
HSMN NewsFeed - 30 Apr 2007
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
HSMN NewsFeed - 30 Apr 2007
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
HSMN NewsFeed - 28 Apr 2007
Greystone Pharmaceuticals, Inc. Announces Appointment of Chief Medical Director
Greystone Pharmaceuticals, Inc. Announces Appointment of Chief Medical Director
HSMN NewsFeed - 27 Apr 2007
FDA Approves INVEGA (TM) for Long-Term Maintenance Treatment of Schizophrenia
FDA Approves INVEGA (TM) for Long-Term Maintenance Treatment of Schizophrenia
HSMN NewsFeed - 27 Apr 2007
Access Pharmaceuticals Announces Expansion of ProLindac(TM) Clinical Trial Sites
Access Pharmaceuticals Announces Expansion of ProLindac(TM) Clinical Trial Sites
HSMN NewsFeed - 27 Apr 2007
Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
HSMN NewsFeed - 27 Apr 2007
Wyeth Chief Financial Officer and Vice Chairman Kenneth J. Martin to Leave the Company
Wyeth Chief Financial Officer and Vice Chairman Kenneth J. Martin to Leave the Company
HSMN NewsFeed - 27 Apr 2007
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-ISOTRETINOIN
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-ISOTRETINOIN
HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
HSMN NewsFeed - 26 Apr 2007
Dyax Announces the Appointment of Gustav Christensen as Executive Vice President and Chief Business Officer
Dyax Announces the Appointment of Gustav Christensen as Executive Vice President and Chief Business Officer
HSMN NewsFeed - 26 Apr 2007
Avantogen Oncology, Inc. Completes Major Transaction With SciClone Pharmaceuticals, Inc.
Avantogen Oncology, Inc. Completes Major Transaction With SciClone Pharmaceuticals, Inc.
HSMN NewsFeed - 26 Apr 2007
Lexicon Genetics Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses
Lexicon Genetics Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses
HSMN NewsFeed - 25 Apr 2007
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
HSMN NewsFeed - 25 Apr 2007
Thallion Pharmaceuticals Inc. Hires Executive Vice-President, Licensing and Development
Thallion Pharmaceuticals Inc. Hires Executive Vice-President, Licensing and Development
HSMN NewsFeed - 25 Apr 2007
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
HSMN NewsFeed - 25 Apr 2007
XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
HSMN NewsFeed - 25 Apr 2007
OctoPlus Gains Full Rights to PolyActive Drug Delivery Technology From IsoTis
OctoPlus Gains Full Rights to PolyActive Drug Delivery Technology From IsoTis
HSMN NewsFeed - 24 Apr 2007
Synovics Pharmaceuticals Appoints David Coffin-Beach President and Chief Operating Officer
Synovics Pharmaceuticals Appoints David Coffin-Beach President and Chief Operating Officer
HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
HSMN NewsFeed - 24 Apr 2007
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
HSMN NewsFeed - 24 Apr 2007
Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
HSMN NewsFeed - 24 Apr 2007
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
HSMN NewsFeed - 24 Apr 2007
Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
HSMN NewsFeed - 24 Apr 2007
New TNS(R) Serum From SkinMedica(R) Exclusively Applied Through HydraFacial MD(TM) by Edge Systems
New TNS(R) Serum From SkinMedica(R) Exclusively Applied Through HydraFacial MD(TM) by Edge Systems
HSMN NewsFeed - 24 Apr 2007
Exelixis Reinitiates Clinical Development of XL999 in Patients With Non-Small Cell Lung Cancer
Exelixis Reinitiates Clinical Development of XL999 in Patients With Non-Small Cell Lung Cancer
HSMN NewsFeed - 24 Apr 2007
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
HSMN NewsFeed - 23 Apr 2007
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
HSMN NewsFeed - 23 Apr 2007
Generex Biotechnology Announces Middle Eastern Licensing Agreement for Generex Oral-lyn(TM)
Generex Biotechnology Announces Middle Eastern Licensing Agreement for Generex Oral-lyn(TM)
HSMN NewsFeed - 23 Apr 2007
Stiefel Laboratories Moves to Solidify, Enhance Its Leadership Position in Dermatology
Stiefel Laboratories Moves to Solidify, Enhance Its Leadership Position in Dermatology
HSMN NewsFeed - 23 Apr 2007
Prana Expands Senior Management Team with Appointment of Two US-based Pharmaceutical Executives
Prana Expands Senior Management Team with Appointment of Two US-based Pharmaceutical Executives
HSMN NewsFeed - 23 Apr 2007
CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application
CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application
HSMN NewsFeed - 23 Apr 2007
DiObex Announces the Appointment of David Cory as Chief Executive Officer
DiObex Announces the Appointment of David Cory as Chief Executive Officer
HSMN NewsFeed - 20 Apr 2007
Abbott Submits New Drug Application for Combination Niaspan(R)/Simvastatin Tablet
Abbott Submits New Drug Application for Combination Niaspan(R)/Simvastatin Tablet
HSMN NewsFeed - 20 Apr 2007
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
HSMN NewsFeed - 20 Apr 2007
BioMS Medical announces lead investigator in United States phase III multiple sclerosis trial
BioMS Medical announces lead investigator in United States phase III multiple sclerosis trial
HSMN NewsFeed - 20 Apr 2007
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
HSMN NewsFeed - 19 Apr 2007
ZARS Announces First European Marketing Approval and License Agreement With EUSA Pharma for Rapydan(R)
ZARS Announces First European Marketing Approval and License Agreement With EUSA Pharma for Rapydan(R)
HSMN NewsFeed - 19 Apr 2007
Valeant Pharmaceuticals Re-Signs Courteney Cox as Kinerase(R) Spokesperson
Valeant Pharmaceuticals Re-Signs Courteney Cox as Kinerase(R) Spokesperson
HSMN NewsFeed - 19 Apr 2007
Abraxis BioScience Receives FDA Tentative Approval for Fosphenytoin Sodium Injection, USP
Abraxis BioScience Receives FDA Tentative Approval for Fosphenytoin Sodium Injection, USP
HSMN NewsFeed - 19 Apr 2007
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
HSMN NewsFeed - 19 Apr 2007
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
HSMN NewsFeed - 19 Apr 2007
Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
HSMN NewsFeed - 19 Apr 2007
Novacea Acquires Worldwide Development and Commercialization Rights for Its Oncology Candidate AQ4N
Novacea Acquires Worldwide Development and Commercialization Rights for Its Oncology Candidate AQ4N
HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
HSMN NewsFeed - 19 Apr 2007
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
HSMN NewsFeed - 18 Apr 2007
Schering-Plough Announces ZETIA Approved in Japan for Treatment of High Cholesterol
Schering-Plough Announces ZETIA Approved in Japan for Treatment of High Cholesterol
HSMN NewsFeed - 18 Apr 2007
Iroko Pharmaceuticals Appoints John Vavricka as President and Chief Executive Officer
Iroko Pharmaceuticals Appoints John Vavricka as President and Chief Executive Officer
HSMN NewsFeed - 18 Apr 2007
Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain
Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain
HSMN NewsFeed - 18 Apr 2007
Genta Announces New Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
Genta Announces New Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
HSMN NewsFeed - 18 Apr 2007
Osteologix Completes Enrollment in Clinical Trial of Investigational Drug for Osteoporosis
Osteologix Completes Enrollment in Clinical Trial of Investigational Drug for Osteoporosis
HSMN NewsFeed - 18 Apr 2007
Pipex Pharmaceuticals Appoints Kay E. Stremler, Ph.D. as Vice President of Manufacturing
Pipex Pharmaceuticals Appoints Kay E. Stremler, Ph.D. as Vice President of Manufacturing
HSMN NewsFeed - 18 Apr 2007
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
HSMN NewsFeed - 17 Apr 2007
Cyclacel Pharmaceuticals Reports Preclinical Seliciclib-Erlotinib Synergy Data at AACR
Cyclacel Pharmaceuticals Reports Preclinical Seliciclib-Erlotinib Synergy Data at AACR
HSMN NewsFeed - 17 Apr 2007
Erimos Pharmaceuticals Names Dr. Scott Mohrland as President and Chief Executive Officer
Erimos Pharmaceuticals Names Dr. Scott Mohrland as President and Chief Executive Officer
HSMN NewsFeed - 17 Apr 2007
SCOLR Pharma Announces Positive Ibuprofen Study Results and Status of Commercialization Program
SCOLR Pharma Announces Positive Ibuprofen Study Results and Status of Commercialization Program
HSMN NewsFeed - 17 Apr 2007
ArteFill 5-Year Data to Be Presented at American Society for Aesthetic Plastic Surgery Annual Meeting
ArteFill 5-Year Data to Be Presented at American Society for Aesthetic Plastic Surgery Annual Meeting
HSMN NewsFeed - 17 Apr 2007
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
HSMN NewsFeed - 17 Apr 2007
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
HSMN NewsFeed - 17 Apr 2007
Hi-Tech Pharmacal Receives Tentative Approval for Ciclopirox Topical Solution
Hi-Tech Pharmacal Receives Tentative Approval for Ciclopirox Topical Solution
HSMN NewsFeed - 16 Apr 2007
YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan
YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan
HSMN NewsFeed - 16 Apr 2007
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
HSMN NewsFeed - 16 Apr 2007
Cegedim SA's Proposed Acquisition of Dendrite International, Inc. Clears U.S. Antitrust Review
Cegedim SA's Proposed Acquisition of Dendrite International, Inc. Clears U.S. Antitrust Review
HSMN NewsFeed - 16 Apr 2007
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
HSMN NewsFeed - 16 Apr 2007
Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer
Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer
HSMN NewsFeed - 16 Apr 2007
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
HSMN NewsFeed - 16 Apr 2007
Diobex Raises $24 Million Series B Financing Led by Inventages Venture Capital
Diobex Raises $24 Million Series B Financing Led by Inventages Venture Capital
HSMN NewsFeed - 16 Apr 2007
Ipsen Appoints Sean McKercher as Vice President of Commercial Development in North America
Ipsen Appoints Sean McKercher as Vice President of Commercial Development in North America
HSMN NewsFeed - 16 Apr 2007
Encysive Pharmaceuticals Announces Launch of THELIN (Sitaxentan Sodium) in the Netherlands
Encysive Pharmaceuticals Announces Launch of THELIN (Sitaxentan Sodium) in the Netherlands
HSMN NewsFeed - 16 Apr 2007
FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status
FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status
HSMN NewsFeed - 13 Apr 2007
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
HSMN NewsFeed - 13 Apr 2007
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
HSMN NewsFeed - 13 Apr 2007
Molecular Insight Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
Molecular Insight Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
HSMN NewsFeed - 13 Apr 2007
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
HSMN NewsFeed - 13 Apr 2007
First Patient Enrolled in Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
First Patient Enrolled in Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
HSMN NewsFeed - 12 Apr 2007
FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA(R) (etoricoxib)
FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA(R) (etoricoxib)
HSMN NewsFeed - 12 Apr 2007
DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
HSMN NewsFeed - 12 Apr 2007
Exelixis Appoints Experienced Clinician and Scientist to Vice President of Translational Medicine
Exelixis Appoints Experienced Clinician and Scientist to Vice President of Translational Medicine
HSMN NewsFeed - 12 Apr 2007
Lupin Receives US FDA Approval for Novel Formulation of Suprax(R) Suspension
Lupin Receives US FDA Approval for Novel Formulation of Suprax(R) Suspension
HSMN NewsFeed - 12 Apr 2007
Synta Pharmaceuticals Corp. Strengthens Oncology Clinical and Commercial Team
Synta Pharmaceuticals Corp. Strengthens Oncology Clinical and Commercial Team
HSMN NewsFeed - 12 Apr 2007
GSK Initiates REPEAT Dosing Study of Its Novel Oral Platelet Growth Factor, PROMACTA(R), in ITP
GSK Initiates REPEAT Dosing Study of Its Novel Oral Platelet Growth Factor, PROMACTA(R), in ITP
HSMN NewsFeed - 12 Apr 2007
Coley Pharmaceutical Group Licenses VaxImmune(TM) to Merck for Use in Vaccine Programs
Coley Pharmaceutical Group Licenses VaxImmune(TM) to Merck for Use in Vaccine Programs
HSMN NewsFeed - 12 Apr 2007
Novartis Completes Its Business Portfolio Restructuring, Divesting Gerber for USD 5.5 Billion to Nestlé
Novartis Completes Its Business Portfolio Restructuring, Divesting Gerber for USD 5.5 Billion to Nestlé
HSMN NewsFeed - 11 Apr 2007
Mike Bernstein Appointed Vice President of Regulatory Affairs, DFB Branded Pharmaceuticals
Mike Bernstein Appointed Vice President of Regulatory Affairs, DFB Branded Pharmaceuticals
HSMN NewsFeed - 11 Apr 2007
Herbert Slade, MD Joins DFB as Chief Medical Officer and Senior Vice President, Medical Affairs
Herbert Slade, MD Joins DFB as Chief Medical Officer and Senior Vice President, Medical Affairs
HSMN NewsFeed - 11 Apr 2007
Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada
Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada
HSMN NewsFeed - 11 Apr 2007
Pro-Pharmaceuticals Receives Letter from the FDA for New Drug Application for DAVANAT(R)/ 5-FU
Pro-Pharmaceuticals Receives Letter from the FDA for New Drug Application for DAVANAT(R)/ 5-FU
HSMN NewsFeed - 11 Apr 2007
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
HSMN NewsFeed - 11 Apr 2007
Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
HSMN NewsFeed - 10 Apr 2007
Amgen Names Robert Bradway Executive Vice President and Chief Financial Officer
Amgen Names Robert Bradway Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 10 Apr 2007
New BIO Study Confirms Innovative Therapies Will Have Minimal Impact on Healthcare Costs
New BIO Study Confirms Innovative Therapies Will Have Minimal Impact on Healthcare Costs
HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
HSMN NewsFeed - 10 Apr 2007
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
HSMN NewsFeed - 10 Apr 2007
Amarin Appoints Declan Doogan to New Position of President-Research and Development
Amarin Appoints Declan Doogan to New Position of President-Research and Development
HSMN NewsFeed - 10 Apr 2007
Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
HSMN NewsFeed - 10 Apr 2007
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
HSMN NewsFeed - 10 Apr 2007
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
HSMN NewsFeed - 10 Apr 2007
GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory Affairs
GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory Affairs
HSMN NewsFeed - 10 Apr 2007
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
HSMN NewsFeed - 9 Apr 2007
GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (ENTEREG/ENTRAREG(R))
GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (ENTEREG/ENTRAREG(R))
HSMN NewsFeed - 9 Apr 2007
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
HSMN NewsFeed - 9 Apr 2007
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
HSMN NewsFeed - 9 Apr 2007
Alpharma Announces New Sales and Marketing Leadership in its Pharmaceuticals Business
Alpharma Announces New Sales and Marketing Leadership in its Pharmaceuticals Business
HSMN NewsFeed - 5 Apr 2007
Akorn, Inc. Names Shawn L. Silvestri, Ph.D. As Vice President, New Product Development
Akorn, Inc. Names Shawn L. Silvestri, Ph.D. As Vice President, New Product Development
HSMN NewsFeed - 5 Apr 2007
One of the Largest-Ever Parkinson's Disease Studies Initiated Across the United States
One of the Largest-Ever Parkinson's Disease Studies Initiated Across the United States
HSMN NewsFeed - 4 Apr 2007
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
HSMN NewsFeed - 4 Apr 2007
Adams Respiratory Therapeutics Highlights the Expansion and Diversification of its Product Portfolio
Adams Respiratory Therapeutics Highlights the Expansion and Diversification of its Product Portfolio
HSMN NewsFeed - 4 Apr 2007
Threshold Pharmaceuticals Appoints David R. Hoffmann to Board of Directors
Threshold Pharmaceuticals Appoints David R. Hoffmann to Board of Directors
HSMN NewsFeed - 4 Apr 2007
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
HSMN NewsFeed - 4 Apr 2007
Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding
Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding
HSMN NewsFeed - 4 Apr 2007
Sculptra(TM), new cosmetic dermatology treatment, creates long-lasting, natural-looking results
Sculptra(TM), new cosmetic dermatology treatment, creates long-lasting, natural-looking results
HSMN NewsFeed - 4 Apr 2007
GTx, Inc. Appoints Ronald A. Morton, Jr. MD, FACS as Chief Medical Officer
GTx, Inc. Appoints Ronald A. Morton, Jr. MD, FACS as Chief Medical Officer
HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
HSMN NewsFeed - 3 Apr 2007
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
HSMN NewsFeed - 3 Apr 2007
Angiotech appoints Chris Dennis as Senior Vice President, Sales and Marketing
Angiotech appoints Chris Dennis as Senior Vice President, Sales and Marketing
HSMN NewsFeed - 3 Apr 2007
FDA Grants Fast Track Designation to Alzheimer's Disease Drug Candidate AZD-103/ELND005
FDA Grants Fast Track Designation to Alzheimer's Disease Drug Candidate AZD-103/ELND005
HSMN NewsFeed - 2 Apr 2007
PDI, Inc. Announces Resignation of Steven K. Budd as President, Sales Services
PDI, Inc. Announces Resignation of Steven K. Budd as President, Sales Services
